4D MOLECULAR THERAPEUTICS IN
FDMTNASDAQ🏆 #2590 by market capEarnings Nov 9US Equity
$14.31▼ $0.18 (−1.24%)
🌙 After hours$14.31▲ 0.00%Regular close · extended-hours price shownTrack FDMT
Get earnings, price moves & breaking news on Telegram
24h▼ 1.2%
7d▼ 2.7%
14d▼ 2.7%
30d▼ 0.3%
ytd▲ 91.3%
1y▲ 63.9%
🏦Market Cap
$748M
Small Cap
📈Revenue Growth (YoY)
+230194.6%
High Growth
📊Gross Margin
42.0%
Healthy
💵FCF Margin
-170.3%
Thin
⚖️P/S Ratio
8.1x
Elevated
Otter Score
64
Fair
4D MOLECULAR THERAPEUTICS IN
FDMTAnalyst Ratings
Price
$14.31
Total
14
Raised
1
Lowered
0
Avg PT
$26.00
H / L
$32 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
B of A Securities | Reiterated | Buy | 2026-09-29 | — | — |
Cantor Fitzgerald | Upgraded | Neutral → Overweight | 2026-09-14 | $20.00 | +39.80% |
HC Wainwright & Co. | Reiterated | Buy | 2026-07-20 | — | — |
Chardan Capital | Reiterated | Buy | 2026-03-19 | $30.00 | +109.60% |
RBC Capital | Reiterated | Outperform | 2026-03-19 | $26.00 | +81.70% |
Barclays | Reiterated | Overweight | 2025-11-11 | $33.00 | +130.60% |
Roth Capital | Reiterated | Buy | 2025-08-12 | — | — |
Goldman Sachs | Reiterated | Buy | 2025-05-09 | $32.00 | +123.60% |
Leerink Partners | Reiterated | Outperform | 2025-01-13 | $17.00 | +18.80% |
Morgan Stanley | Reiterated | Underweight | 2025-01-13 | $6.00 | −58.10% |
BMO Capital | Reiterated | Outperform | 2024-07-18 | $40.00 | +179.50% |
Jefferies | Reiterated | Buy | 2024-04-01 | $58.00 | +305.30% |
SVB Securities | Reiterated | Market Perform | 2023-04-13 | — | — |
SVB Leerink | Reiterated | Market Perform | 2023-02-06 | — | — |
Institution
B of A Securities
Reiterated · Buy · 2026-09-29
—
—
Cantor Fitzgerald
Upgraded · Neutral → Overweight · 2026-09-14
$20.00
+39.80%
HC Wainwright & Co.
Reiterated · Buy · 2026-07-20
—
—
Chardan Capital
Reiterated · Buy · 2026-03-19
$30.00
+109.60%
RBC Capital
Reiterated · Outperform · 2026-03-19
$26.00
+81.70%
Barclays
Reiterated · Overweight · 2025-11-11
$33.00
+130.60%
Roth Capital
Reiterated · Buy · 2025-08-12
—
—
Goldman Sachs
Reiterated · Buy · 2025-05-09
$32.00
+123.60%
Leerink Partners
Reiterated · Outperform · 2025-01-13
$17.00
+18.80%
Morgan Stanley
Reiterated · Underweight · 2025-01-13
$6.00
−58.10%
BMO Capital
Reiterated · Outperform · 2024-07-18
$40.00
+179.50%
Jefferies
Reiterated · Buy · 2024-04-01
$58.00
+305.30%
SVB Securities
Reiterated · Market Perform · 2023-04-13
—
—
SVB Leerink
Reiterated · Market Perform · 2023-02-06
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space